Education
About Us
Working with TipRanks
Follow Us
Growth Equity Opportunities Fund, Llc Insider Profile
4 Followers
Growth Equity Opportunities Fund, Llc, Ten Percent Owner at Sunesis Pharma, holds 4.66M shares in Sunesis Pharma (Ticker: SNSS). Most recently, Growth Equity Opportunities Fund, Llc Sold $266,700 shares of Sunesis Pharma on Aug 29, 2014 for an estimated value of 2.13M.
Growth Equity Opportunities Fund, Llc Sunesis Pharma (SNSS)Ten Percent Owner
Sunesis Pharma (SNSS)
Ten Percent Owner
Ranked #15,126 out of 78,810 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+48.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Growth Equity Opportunities Fund, Llc's holdings
Insider Roles
Ten Percent Owner
Roles that Growth Equity Opportunities Fund, Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Growth Equity Opportunities Fund, Llc
Growth Equity Opportunities Fund, Llc's Trading History
List of latest transactions for each holding click on a transaction to see Growth Equity Opportunities Fund, Llc's performance on stock
You May Also Like
Growth Equity Opportunities Fund, Llc insider profile FAQ
What is the percentage of profitable transactions made by Growth Equity Opportunities Fund, Llc?
The percentage of profitable transactions made by Growth Equity Opportunities Fund, Llc is 67%.
What is the average return per transaction made by Growth Equity Opportunities Fund, Llc?
The average return per transaction made by Growth Equity Opportunities Fund, Llc is 48.00%.
What stocks does Growth Equity Opportunities Fund, Llc hold?
Growth Equity Opportunities Fund, Llc holds: SNSS stocks.
What was Growth Equity Opportunities Fund, Llc’s latest transaction?
Growth Equity Opportunities Fund, Llc latest transaction was an Informative Sell of $2.13M.
What was Growth Equity Opportunities Fund, Llc's most profitable transaction?
Growth Equity Opportunities Fund, Llc’s most profitable transaction was an Informative Sell of SNSS stock on August 29, 2014. The return on the trade was 83.80%.
What is Growth Equity Opportunities Fund, Llc's role in Sunesis Pharma?
Growth Equity Opportunities Fund, Llc's role in Sunesis Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.